Evidence map›Paper›PMID 39168923›Full record

ArticleStem cell reviews and reports2024

Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs).

Michele Manganelli, Elena Laura Mazzoldi, Rosalba Monica Ferraro, Marinella Pinelli, Marta Parigi, Seyed Ali Mir Aghel, Mattia Bugatti, Ginetta Collo, Gabriele Stocco, William Vermi and 4 more

Abstract read
In one paragraph

Article in Stem cell reviews and reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Current Development of iPSC-Based Modeling in Neurodegenerative Diseases.International journal of molecular sciences · 2025
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michele ManganelliAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.ORCID 0000-0002-8219-0252
Elena Laura MazzoldiAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Rosalba Monica FerraroAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Marinella PinelliAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Marta ParigiAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Seyed Ali Mir AghelAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Mattia BugattiDepartment of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Ginetta ColloDivision of Farmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy.
Gabriele StoccoClinical Department of Medical, Surgical and Health Sciences, University of Trieste, 34127, Trieste, Italy.
William VermiDepartment of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.
Stefania MasneriDivision of Immunohematology and Transfusion Medicine, ASST Spedali Civili Di Brescia, 25123, Brescia, Italy.
Camillo AlmiciDivision of Immunohematology and Transfusion Medicine, ASST Spedali Civili Di Brescia, 25123, Brescia, Italy.
Luigi MoriDepartment of Clinical and Experimental Sciences (DSCS), University of Brescia, 25123, Brescia, Italy.
Silvia GilianiAngelo Nocivelli Institute for Molecular Medicine, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy. silvia.giliani@unibs.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induced Pluripotent Stem Cells (iPSCs) are nowadays a common starting point for wide-ranging applications including 3D disease modeling (i.e. organoids) and in future regenerative medicine. Physiological processes like homeostasis, cell differentiation, development and reproduction are tightly regulated by hormones through binding to their transmembrane or nuclear receptors of target cells. Considering their pleiotropic effect, take into account also their expression in an iPSCs-based disease modeling would better recapitulate the molecular events leading to 3D organoid development and disease study. Here we reported the expression pattern of estrogen receptor (ERα) and progesterone receptor (PR) in four different iPSCs, obtained from CD34 + progenitor cells and skin fibroblasts with four different methods. Expression of ERα and PR mRNA were significantly downregulated in iPSCs as well as fibroblasts compared to MCF7 positive control. Immunofluorescence (IF) staining detected only the expression of PR protein in all the different iPSCs cell lines, while ERα was not detectable. By flow cytometry analysis we observed that the ~ 65% of the total population of iPSCs cells expressed only PR, with 100% fold increase compared to HSPCs and fibroblasts, while ERα was not expressed. Our results collectively demonstrated for the first time that the reprogramming of somatic cells into iPSCs leads to the expression of PR receptor.

Indexed as

Estrogen Receptor alphaFibroblastsInduced Pluripotent Stem CellsReceptors, ProgesteroneAntigens, CD34Cell DifferentiationCellular ReprogrammingHumansMCF-7 CellsRNA, MessengerAntigens, CD34Estrogen Receptor alphaReceptors, ProgesteroneRNA, MessengerCD34DifferentiationEstrogen receptorFibroblastsInduced pluripotent stem cells (iPSCs)Progesterone receptor

Identifiers

PMID39168923
PMCPMC11554879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.